UNSPSC 51331500: Antipsychotic benzene derivatives

Antipsychotic drugs made from a toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation.

UNSPSC 51331500 Antipsychotic benzene derivatives is a Class code that, based on recent state and local solicitations, encompasses pharmaceutical procurement far broader than its nominal scope—including naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products sourced through authorized wholesalers and direct-to-manufacturer channels. State and local issuing bodies using this code span county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and cooperative purchasing alliances serving multi-state and multi-jurisdictional networks (Minnesota Multistate Cooperative Purchasing Alliance). The work involves competitive procurement of pharmaceutical products with defined National Drug Codes, compliance with FDA manufacturing standards, Drug Supply Chain Security Act certification, and delivery logistics to designated health facilities and distribution centers.

Recent activity shows concentration in Florida and the upper Midwest and Texas. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, requiring vendors to provide fixed-fee pricing and maintain workers' compensation, commercial general liability, and professional liability insurance. The Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) to explore direct-to-manufacturer prescription fulfillment models and vendor capabilities for a Therapeutic Pharmacy Initiative, signaling preliminary market research before formal solicitation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), with awards effective July 1, 2026 and evaluation weighted 75 percent on price competitiveness and 25 percent on administrative compliance, insurance coverage, and EDI capability. Vendors must certify cGMP and DSCSA compliance and maintain contractual relationships with at least two of the three authorized wholesalers.